Lnc2Cancer

Experimentally Supported Human LncRNA and Cancer Associations Database

LncRNA centric

Cancer centric

Advanced search

Drug resistant

Circulating

Prognosis

Detail


   LncRNA Name lnc-ZNF180-2
   Synonyms ZNF180, HHZ168
   Region GRCh38_19:44474428-44500524    Sequence
   Ensembl ENSG00000167384
   RefSeq NA
   Circulating
   Drug-resisitant
   Prognostic
   MiRNA
   Variant
   TF
   Methylation
   Cancer Name clear cell renal cell carcinoma
   ICD-0-3 C64.9  M8005/0
   Methods microarray, qPCR etc.
   Sample ccRCC tissues
   Expression Pattern down-regulated
   Function Description

lnc-ZNF180-2 levels were similar in localized ccRCC and normal renal tissue, but we observed a significant increase of lnc-ZNF180-2 expression in advanced ccRCC tissue. Furthermore, lnc-ZNF180-2 expression levels were an independent predictor of progression-free survival, cancer-specific survival and overall survival in ccRCC patients. We also observed that lnc-CYP4A22-2/3 expression levels allowed discrimination of ccRCC and normal renal tissue. In conclusion, lncRNAs are involved in renal carcinogenesis, and quantification of lnc-ZNF180-2 may be useful for the prediction of ccRCC patients outcome following nephrectomy.

   Pubmed ID 26609485
   Year 2015
   Title The long non-coding RNA lnc-ZNF180-2 is a prognostic biomarker in patients with clear cell renal cell carcinoma.
   External Links
   Links for  lnc-ZNF180-2 GenBank       HGNC       lncrnadb       Noncode
   Links for  clear cell renal cell carcinoma Omim       Cosmic

CopyRight © College of Bioinformatics Science and Technology, Harbin Medical University, China.